DK2231166T3 - Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer - Google Patents

Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer

Info

Publication number
DK2231166T3
DK2231166T3 DK08862479.6T DK08862479T DK2231166T3 DK 2231166 T3 DK2231166 T3 DK 2231166T3 DK 08862479 T DK08862479 T DK 08862479T DK 2231166 T3 DK2231166 T3 DK 2231166T3
Authority
DK
Denmark
Prior art keywords
gemcitabine
triglycerides
salts
treatment
medium
Prior art date
Application number
DK08862479.6T
Other languages
Danish (da)
English (en)
Inventor
Lyne Gagnon
Lilianne Geerts
Christopher Penney
Original Assignee
Prometic Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prometic Biosciences Inc filed Critical Prometic Biosciences Inc
Application granted granted Critical
Publication of DK2231166T3 publication Critical patent/DK2231166T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK08862479.6T 2007-12-19 2008-12-18 Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer DK2231166T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US812907P 2007-12-19 2007-12-19
PCT/CA2008/002190 WO2009076761A1 (en) 2007-12-19 2008-12-18 Medium-chain length fatty acids, salts and triglycerides in combination with gemcitabine for treatment of pancreatic cancer

Publications (1)

Publication Number Publication Date
DK2231166T3 true DK2231166T3 (da) 2013-06-24

Family

ID=40795145

Family Applications (1)

Application Number Title Priority Date Filing Date
DK08862479.6T DK2231166T3 (da) 2007-12-19 2008-12-18 Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer

Country Status (15)

Country Link
US (1) US8946190B2 (enExample)
EP (1) EP2231166B1 (enExample)
JP (1) JP5473937B2 (enExample)
KR (1) KR101603351B1 (enExample)
CN (1) CN101903028B (enExample)
AU (1) AU2008338204B2 (enExample)
BR (1) BRPI0821395A2 (enExample)
CA (1) CA2708679C (enExample)
DK (1) DK2231166T3 (enExample)
ES (1) ES2414617T3 (enExample)
MX (1) MX2010006867A (enExample)
NZ (1) NZ586249A (enExample)
PT (1) PT2231166E (enExample)
TW (1) TWI448290B (enExample)
WO (1) WO2009076761A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2575100T3 (es) 2009-05-04 2016-06-24 Prometic Pharma Smt Limited Compuestos aromáticos sustituidos y usos farmacéuticos de los mismos
EA030038B1 (ru) 2010-10-27 2018-06-29 Прометик Фарма Смт Лимитед Применение соединений для лечения рака и способ лечения рака
CN102617679B (zh) * 2012-03-13 2014-11-26 北京大学 一种共轭亚油酸与吉西他滨连接的前体药物制备方法及其应用
JP6396333B2 (ja) 2013-02-12 2018-09-26 ベンド・リサーチ・インコーポレーテッドBend Research,Incorporated 低水溶性活性物質の固体分散体
US9737538B2 (en) 2013-02-12 2017-08-22 Bend Research, Inc. Solid dispersions of low-water solubility actives
KR102213143B1 (ko) * 2013-02-28 2021-02-08 바스프 에이에스 지방질 화합물, 트리글리세리드 및 계면활성제를 포함하는 조성물 및 이를 이용하는 방법
US10463684B2 (en) 2014-01-29 2019-11-05 Board Of Regents, The Uneversety Of Texas System Nucleobase analogue derivatives and their applications
CN120923343A (zh) 2018-10-11 2025-11-11 巴斯夫股份公司 芳族化合物及其医药用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1990010441A1 (en) * 1989-03-13 1990-09-20 Thornfeldt Carl R Treatment of skin diseases and tumors
US6340705B1 (en) * 1999-09-10 2002-01-22 Monsanto Technology, Llc Use of α-linolenic acid metabolites for treatment or prevention of cancer
EP1900364B1 (en) 2001-04-18 2013-09-25 ProMetic BioSciences Inc. Medium-chain length fatty acids, glycerides and analogues as neutrophil survival and activation factors
CA2457526A1 (en) * 2001-08-29 2003-03-13 Umd, Inc. Vaginal delivery of chemotherapeutic agents and inhibitors of membrane efflux systems for cancer therapy
US20060012880A1 (en) * 2002-05-02 2006-01-19 Law Benjamin P Optical device with refractive and diffractive properties
CN100427081C (zh) * 2003-02-07 2008-10-22 普罗米蒂克生物科学公司 作为红细胞生成刺激剂的中链长脂肪酸类、甘油酯类和类似物
ES2264886B1 (es) * 2005-05-12 2008-02-01 Proyecto Empresarial Brudy, S.L. Utilizacion de acido docosahexaenoico para el tratamiento de enfermedades tumorales.

Also Published As

Publication number Publication date
US8946190B2 (en) 2015-02-03
ES2414617T3 (es) 2013-07-22
CA2708679C (en) 2016-11-15
CN101903028B (zh) 2013-06-05
JP5473937B2 (ja) 2014-04-16
EP2231166B1 (en) 2013-03-20
BRPI0821395A2 (pt) 2015-06-16
JP2011506492A (ja) 2011-03-03
KR20100101134A (ko) 2010-09-16
TW200934494A (en) 2009-08-16
KR101603351B1 (ko) 2016-03-14
EP2231166A1 (en) 2010-09-29
AU2008338204A1 (en) 2009-06-25
TWI448290B (zh) 2014-08-11
EP2231166A4 (en) 2012-02-22
AU2008338204B2 (en) 2015-03-05
WO2009076761A1 (en) 2009-06-25
NZ586249A (en) 2012-05-25
MX2010006867A (es) 2010-08-31
CN101903028A (zh) 2010-12-01
HK1151244A1 (en) 2012-01-27
CA2708679A1 (en) 2009-06-25
US20100273731A1 (en) 2010-10-28
PT2231166E (pt) 2013-06-17

Similar Documents

Publication Publication Date Title
DK2231166T3 (da) Fedtsyrer med medium kædelængde, salte og triglycerider i kombination med gemcitabin til behandling af pankreascancer
DK2114419T3 (da) Natriummetaarsenit til anvendelse i behandling af smerte og inflammation
DK2193198T3 (da) Varmestabil asparaginase til reduktion af acrylamid i levneds- eller nydelsesmidler
DK2473510T3 (da) Jak-2-hæmmere og anvendelse heraf til behandling af myeloproliferativesygdomme og cancer
BRPI0818287A2 (pt) células dendríticas manipuladas e usos para o tratamento do câncer.
DK2483278T3 (da) Benzoxazepin pi3k-inhibitorforbindelser og deres anvendelse i behandlingen af cancer
DK2350416T4 (da) Multipel rude med mindst én antirefleksbehandling og anvendelse af antirefleksbehandling i multipel rude
DK2073811T3 (da) Kinaseinhibitorer anvendelige til behandling af myeloproliferative sygdomme og andre proliferative sygdomme
BRPI0807717A2 (pt) Inibidores de quinase úteis para o tratamento de doenças mieloproliferativas e outras doenças proliferativas.
EP2124771A4 (en) DEVICES AND METHODS FOR EXTRACORPORAL ABLATION OF CIRCULATING CELLS
DK2155188T3 (da) Fremgangsmåder og sammensætninger til behandling af tilbagevendende kræft
DK1911756T3 (da) Substituerede pyridinyl- og pyrimidinylderivater som modulatorer af metabolisme og behandling af forstyrrelser relateret dertil
DK2127652T3 (da) Fremgangsmåde til behandling af cancer under anvendelse af anticancermiddel i kombination
BRPI1006371A2 (pt) "método para criar espaço em uma articulação, cateter-balão de espaçamento de articulação, e coluna perineal"
DK3095447T3 (da) Behandling af vitamin d-insufficiens og -mangel med 25-hydroxyvitamin d2 og 25-hydroxyvitamin d3
DK2259674T3 (da) Delta-4-desaturase og anvendelse heraf i fremstillingen af flerumættedefedtsyrer
DK2235002T3 (da) 4-pyridinonforbindelser og anvendelse heraf til behandling af cancer
BRPI0921022A2 (pt) tratamento com pirfenidona para pacientes com função hepática atípica
DK2342233T3 (da) Anti-CXCR4-antistoffer og anvendelse deraf i behandling af cancer
DK2340042T3 (da) Fremgangsmåder og præparater til behandling af cancer
DK2101805T3 (da) Integrinligander til anvendelse i behandling af cancer
DK2297106T3 (da) Phenoxypyridinylamidderivater og deres anvendelse til behandling af pde4-medierede sygdomstilstande
DK2100604T3 (da) Dicarboxylsyrer med medium kæde og deres derivater og metaboliske lidelser
BRPI0816712A2 (pt) terapia de intervalo para o tratamento de tinnitus
DK2063881T3 (da) Sammensætning og fremgangsmåde til virksom og sikker administration af halopyruvat til behandlingen af cancer